Journal article
Prebiotic-supplemented partially hydrolysed cow's milk formula for the prevention of eczema in high-risk infants: A randomized controlled trial
RJ Boyle, MLK Tang, WC Chiang, MC Chua, I Ismail, A Nauta, JOB Hourihane, P Smith, M Gold, J Ziegler, J Peake, P Quinn, R Rao, N Brown, A Rijnierse, J Garssen, JO Warner, C Axelrad, S Jeffries, Y Donald Show all
Allergy European Journal of Allergy and Clinical Immunology | Published : 2016
DOI: 10.1111/all.12848
Abstract
Background Prevention guidelines for infants at high risk of allergic disease recommend hydrolysed formula if formula is introduced before 6 months, but evidence is mixed. Adding specific oligosaccharides may improve outcomes. Objective To evaluate whether partially hydrolysed whey formula containing oligosaccharides (0.8 g/100 ml) (pHF-OS) can prevent eczema in high-risk infants [ISRCTN65195597]. Methods We conducted a parallel-group, multicentre, randomized double-blind controlled trial of pHF-OS vs standard cow's milk formula. Infants with a family history of allergic disease were randomized (stratified by centre/maternal allergy) to active (n = 432) or control (n = 431) formula until 6 m..
View full abstractGrants
Funding Acknowledgements
RJB and JOW are supported by a National Institute for Health Research Biomedical Research Centre and the MRC and Asthma UK Centre in Allergic Mechanisms of Asthma.